Product Information
HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.1354 per EA under NDC 31722094201. Its NADAC has been published 378 times since Jul 10, 2019.
FDA first approved this application on Nov 7, 2018. Its Orange Book therapeutic-equivalence code is AA.
Strength
325; 7.5 mg/1; mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722094201
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ACETAMINOPHEN; HYDROCODONE BITARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA211487FDA Approved
11/7/2018
TE Code
AA
On Market Since
8/22/2025
Pharmacological Classes
Price Statistics
The NADAC for HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET has been published 378 times since Jul 10, 2019, and over the history we have for it it has risen 28.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1354 per EA |
|---|---|
| All-time high | $0.1630 (Jul 10, 2024) |
| All-time low | $0.0932 (Dec 18, 2019) |
| 52-week high | $0.1522 |
| 52-week low | $0.1354 |
| Median price | $0.1335 |
| Average price | $0.1325 |
| Largest weekly change | +41.5% (Jan 22, 2020) |
| Weeks tracked | 378 |
| Tracking since | Jul 10, 2019 |
Generic Alternatives
The matcher finds 13 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Camber Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Hydrocodone Bitartrate and Acetaminophen market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET, manufactured by Camber Pharmaceuticals Inc., is $0.1354 per EA (NDC 31722094201), effective Sep 30, 2026.
How has the price of HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET changed over time?
Over the history we have for it, the NADAC for HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET has risen 28.9%. It has been tracked across 378 weekly CMS publications since Jul 10, 2019.
What are the highest and lowest recorded NADAC prices for HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET?
Since Jul 10, 2019, the NADAC for HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET has ranged from a low of $0.0932 (Dec 18, 2019) to a high of $0.1630 (Jul 10, 2024), with a median of $0.1335 per EA.
Are there cheaper alternatives to HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET?
Yes. 13 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET, is $0.1272 per EA — about 6% below HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET.
Who manufactures HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET?
HYDROCODONE-ACETAMINOPHEN 7.5-325 MG TABLET (NDC 31722094201) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.